Neurosnap
Neurosnap is a cloud-based computational biology platform that gives researchers code-free browser access to 100+ AI-powered bioinformatics tools for protein structure prediction, design, docking, molecular dynamics, and binder engineering, serving academic and pharma scientists globally.
- Company typePrivate
- Founded2022
- HeadquartersWilmington, United States
- Headcount1–10
- GTM typeB2B and B2C
- OfferingSoftware
What Neurosnap does
Neurosnap Inc. is a privately held computational biology software company founded in 2022 and registered in Delaware (headquartered in Wilmington), operating with 1-10 employees. It runs a cloud platform that delivers 100+ curated, browser-based bioinformatics tools spanning protein structure prediction (AlphaFold2, Chai-1, Boltz-1, OpenFold3, RoseTTAFold3), protein and binder design (NeuroFold, BoltzGen, RFdiffusion2, ProGen2, DiffAb), molecular docking (DiffDock-L, PocketFlow, GNINA), molecular dynamics (GROMACS), cryo-EM processing (CryoAtom, CryoSAMU, DeepEMhancer), and ADMET/toxicity prediction. The platform is differentiated by proprietary NeuroFold enzyme optimization (claiming 100% experimental wet-lab success and 40x Spearman rank correlation improvement versus Meta's ESM-1v) and BoltzGen all-atom diffusion for binder design (66%/80% success rates across 10 campaigns).
The platform is accessed via a no-installation web workspace, REST API, and a Python SDK distributed on GitHub, enabling both code-free use by bench scientists and programmatic automation by computational teams. Pricing is freemium for academic users, tiered monthly subscriptions from $6.99 to $79.99 for individuals and small labs, and custom enterprise licensing for commercial use. Neurosnap reports 5,000+ organizations, 50,000+ scientists, and 250,000+ jobs submitted across 50+ countries, with named users spanning NIH, FDA, Harvard, MIT, Stanford, Oxford, Princeton, Penn, Roche, Bayer, Takeda, Biogen, Regeneron, Samsung, Illumina, GenScript, Ajinomoto, and Vividion Therapeutics. The company is founder-led (CEO Keaun Amani), privately held, has not publicly disclosed revenue or a meaningful funding history beyond a $300,000 round from Tiferes Ventures in May 2023, and claims ISO 27001-aligned security with full IP retention for users.
Neurosnap firmographics
Firmographics- Name
- Neurosnap
- Legal name
- Neurosnap Inc.
- Website
- https://neurosnap.ai
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Neurosnap is a cloud-based computational biology platform that gives researchers code-free browser access to 100+ AI-powered bioinformatics tools for protein structure prediction, design, docking, molecular dynamics, and binder engineering, serving academic and pharma scientists globally.
- Ownership category
- akta.pro rank
Neurosnap industry classification
Industry- Product category
- Computational Biology Software
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Computer Systems Design and Related Services (54151)
- SIC
- Services-Computer Integrated Systems Design (7373)
- akta.pro primary industry
- Protein Engineering & Directed Evolution Platforms (enzyme/therapeutic protein optimization) (HLAAAIAC)
Keywords
Where Neurosnap is headquartered
LocationHeadquarters
- HQ city
- Wilmington
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Neurosnap business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Technology or R&D, Infrastructure, Personnel, Marketing or Sales, Operations
Revenue model
- Subscription Plans (Tiered): Monthly or annual subscription tiers offering compute credits, parallel jobs, and tier-specific features. Credits do not expire. Higher tiers provide more credits, parallel jobs, and priority access. Annual billing offers up to 20% savings.
- Usage-Based Credits: Compute credits consumed based on job runtime and tool's credit usage rate. Credits purchased through subscription plans; additional credits can be purchased or renewed.
- Enterprise Licensing: Custom enterprise solutions for businesses with commercial use rights, unlimited users, unlimited parallel jobs, access to Neurosnap Teams, custom models/pipelines, and tailored pricing.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Monthly | Free tier for initial exploration |
| Subscription | Monthly | Budget plan for light computational needs |
| Subscription | Monthly | Best value for active research projects |
| Subscription | Monthly | Academic research with higher compute demands |
| Subscription | Monthly | Professional plan for large-scale computation |
| Subscription | Multi-year contract | Enterprise solutions for businesses |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels5 records
Neurosnap product offering
Product offeringCore offering
Neurosnap is a browser-based computational biology and cheminformatics platform that hosts 100+ curated bioinformatics tools for protein structure prediction, protein and binder design, molecular docking, antibody engineering, molecular dynamics, and ADMET/toxicity analysis. The platform provides code-free access to hosted AI/ML models (including proprietary NeuroFold and BoltzGen) alongside a Python SDK and REST API for programmatic workflow automation, eliminating the need for local installation of complex computational biology software.
Product overview
Neurosnap is a browser-based computational biology platform offering access to 100+ hosted bioinformatics tools for structure prediction, binder design, docking, screening, and downstream analysis workflows. The platform is built around a unified web interface complemented by the Neurosnap SDK Python package and REST API for programmatic access. Key tool categories include protein folding (AlphaFold2, Chai-1, Boltz-1, OpenFold3, RoseTTAFold3), protein design (NeuroFold, RFdiffusion2, ProGen2, BoltzGen), antibody engineering (DiffAb, AntiFold, Immune Builder), molecular docking (DiffDock-L, PocketFlow, GNINA, LightDock), and cryo-EM processing (CryoAtom, CryoSAMU, DeepEMhancer). The platform also provides GROMACS molecular dynamics simulations, Pipelines for workflow automation, Teams for collaboration, and specialized tools for toxicity prediction (eTox), ADMET analysis, expression optimization, and protein annotation. NeuroFold is a proprietary enzyme optimization service with published experimental validation, while BoltzGen provides universal binder design using all-atom diffusion models.
Differentiator
Problem solved
Functional benefit
Brands
- NeuroFold: A proprietary protein design and enzyme optimization tool offered on the Neurosnap platform, featuring structure prediction and multi-property optimization capabilities.
- Neurosnap API
- Neurosnap SDK
- Neurosnap Teams
- NeuroBind
Products and services
- Neurosnap Platform
- Neurosnap SDK (Python Package)
- Neurosnap API
- NeuroFold
- BoltzGen
- NeuroBind
- Neurosnap Teams
Quantifiable outcome
- 100% experimental success rate for NeuroFold-designed enzyme variants in wet-lab validation
- +3 more outcomes
Companies that use Neurosnap
Customer profileNamed customers18 records
Segments4 records
Ideal customer profiles4 records
Neurosnap technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability12 records
Feature8 records
Neurosnap partnerships and signals
Strategic signalScale indicators5 records
Recent moves6 records
Expansion highlights6 records
Neurosnap competitors and assessment
Company assessmentDirect peers
- Schrödinger: Schrödinger provides a computational chemistry and molecular simulation platform for drug discovery, including protein structure prediction, free-energy calculations, and ligand docking—directly overlapping Neurosnap's protein folding, docking, and ADMET tooling for life sciences R&D customers.
- Benchling: Benchling is a cloud R&D platform for life sciences combining ELN, LIMS, and informatics workflows; it competes with Neurosnap for biotech and pharma compute and collaboration budgets, though its strengths are data management rather than structural biology models.
- DNAnexus: DNAnexus offers a biomedical informatics cloud platform used by NIH, FDA, and major pharma for genomics and multi-omics pipelines—directly comparable to Neurosnap's cloud-hosted bioinformatics and compliance posture for enterprise life sciences customers.
- Cyrus Biotechnology: Cyrus Biotechnology sells protein engineering software (including the Rosetta/PyRosetta-based Protein Design platform and Bench) to pharma and biotech—the closest direct competitor to Neurosnap's NeuroFold, NeuroBind, and AlphaFold-class structure prediction offerings.
- OpenEye Scientific (Cadence): OpenEye, now part of Cadence, provides computational chemistry and molecular modeling SaaS (OEDocking, Orion, etc.) for drug discovery—directly competing with Neurosnap's docking, ADMET, and small molecule discovery tools.
- Seven Bridges (Velsera): Seven Bridges / Velsera provides a cloud bioinformatics and multi-omics analysis platform serving pharma, NIH, and consortia—directly comparable to Neurosnap in cloud-hosted life sciences analysis workflows and enterprise customers.
- Lifebit: Lifebit offers a federated genomics and biomedical data platform for pharma and research institutions, overlapping Neurosnap's cloud-hosted bioinformatics and compliance-focused enterprise positioning.
Broad incumbents
- Dotmatics: Dotmatics (Insightful Science, now part of Siemens) is an established life sciences R&D platform spanning ELN, LIMS, biology, and chemistry informatics; it overlaps Neurosnap's pharma/biotech target market with a broader scientific data management portfolio.
- BIOVIA (Dassault Systèmes): BIOVIA offers enterprise discovery, modeling, and simulation suites (including molecular dynamics and biologics design) for large pharma—a broad incumbent competing for the same enterprise life sciences compute budget as Neurosnap.
Emerging players
- Atomwise: Atomwise is an AI-driven small molecule drug discovery company using structure-based and convolutional neural networks for hit identification—an emerging player with overlapping AI-for-drug-discovery positioning to Neurosnap's docking and ADMET stack.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
Neurosnap social profiles
Digital presenceNeurosnap compliance and trust
Trust signalCompliance1 record
Neurosnap financial estimates
Financial estimateRevenue estimate
Valuation estimate
Neurosnap leadership team
Management profileNumber of profiles
Profiles1 record
Neurosnap funding detail
Funding detailFunding overview
Funding rounds2 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Neurosnap M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Neurosnap
What does Neurosnap do?
Neurosnap is a browser-based computational biology and cheminformatics platform that hosts 100+ curated bioinformatics tools for protein structure prediction, protein and binder design, molecular docking, antibody engineering, molecular dynamics, and ADMET/toxicity analysis. The platform provides code-free access to hosted AI/ML models (including proprietary NeuroFold and BoltzGen) alongside a Python SDK and REST API for programmatic workflow automation, eliminating the need for local installation of complex computational biology software.
Is Neurosnap a public or private company?
Neurosnap is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Neurosnap founded?
Neurosnap was founded in 2022. It employs 1 to 10 people.
Where is Neurosnap based?
Neurosnap is headquartered in Wilmington, United States, in the North America region.
How does Neurosnap make money?
Three revenue lines are on record. Subscription Plans (Tiered) is the primary driver. The others are usage-Based Credits and enterprise Licensing.
Who are Neurosnap's main competitors?
Direct peers on record are Schrödinger, Benchling, DNAnexus, Cyrus Biotechnology, OpenEye Scientific (Cadence), Seven Bridges (Velsera) and Lifebit. Broad incumbents are Dotmatics and BIOVIA (Dassault Systèmes). Atomwise is listed as an emerging player.
Does Neurosnap have an API?
Yes. Neurosnap offers a REST API that enables programmatic access to all platform services and tools. Users can submit jobs, retrieve results, manage team collaboration, stream outputs, and integrate Neurosnap into existing pipelines. The API uses API key authentication via the X-API-KEY header and accepts multipart/form-data for job submissions. Endpoints include /api/services (list available tools), /api/jobs (view submitted jobs), /api/job/submit/SERVICE_NAME (submit jobs), /api/job/status/JOB_ID (check job status), /api/job/cancel/JOB_ID (cancel jobs), /api/job/data/JOB_ID (fetch job configuration and files), /api/job/file/JOB_ID/[in/out]/FILE_NAME (download specific files), /api/job/note/set (set job notes), /api/job/share/set/JOB_ID (enable job sharing), /api/job/share/delete/JOB_ID (disable job sharing), /api/job/copy/JOB_ID (duplicate jobs), /api/teams/info (fetch team information), and /api/teams/jobs (view team jobs). The API is available to all users and supports JSON responses for most endpoints. Developer documentation is at neurosnap.ai/blog/post/full-neurosnap-api-tutorial-the-quick-easy-api-for-bioinformatics/66b00dacec3f2aa9b4be703a.
What industry is Neurosnap in?
Neurosnap's product category is Computational Biology Software. Its primary akta.pro industry code is HLAAAIAC, Protein Engineering & Directed Evolution Platforms (enzyme/therapeutic protein optimization). Its NAICS code is 541714 and its SIC code is 7373.